{"id":"https://openalex.org/W4387798656","doi":"https://doi.org/10.1161/circulationaha.123.065529","title":"Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia","display_name":"Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia","alternate_titles":[],"publication_year":2023,"publication_date":"2023-10-20","ids":{"openalex":"https://openalex.org/W4387798656","doi":"https://doi.org/10.1161/circulationaha.123.065529","pmid":"https://pubmed.ncbi.nlm.nih.gov/37860863","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10814999"},"language":"en","primary_location":{"id":"doi:10.1161/circulationaha.123.065529","doi":"https://doi.org/10.1161/circulationaha.123.065529","is_oa":true,"landing_page_url":"https://doi.org/10.1161/circulationaha.123.065529","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.123.065529","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4387798656"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.123.065529","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020436935","display_name":"Albert Wiegman","orcid":"https://orcid.org/0000-0001-6223-5671","observed_orcids":["https://orcid.org/0000-0001-6223-5671"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Albert Wiegman","raw_affiliation_strings":["Department of Paediatrics, Amsterdam University Medical Centers, Location University of Amsterdam, The Netherlands (A.W., M.D.R.)"],"raw_orcid":"https://orcid.org/0000-0001-6223-5671","affiliations":[{"raw_affiliation_string":"Department of Paediatrics, Amsterdam University Medical Centers, Location University of Amsterdam, The Netherlands (A.W., M.D.R.)","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I4210151833","https://openalex.org/I887064364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056391304","display_name":"Susanne Greber\u2010Platzer","orcid":"https://orcid.org/0000-0002-3706-8370","observed_orcids":["https://orcid.org/0000-0002-3706-8370"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Susanne Greber-Platzer","raw_affiliation_strings":["Department of Pediatrics and Adolescent Medicine, Division of Pediatric Pulmonology, Allergology and Endocrinology, Medical University of Vienna, Austria (S.G.-P.)","Susanne Greber-Platzer https://orcid.org/0000-0002-3706-8370 Department of Pediatrics and Adolescent Medicine, Division of Pediatric Pulmonology, Allergology and Endocrinology, Medical University of Vienna, Austria (S.G.-P.)"],"raw_orcid":"https://orcid.org/0000-0002-3706-8370","affiliations":[{"raw_affiliation_string":"Department of Pediatrics and Adolescent Medicine, Division of Pediatric Pulmonology, Allergology and Endocrinology, Medical University of Vienna, Austria (S.G.-P.)","institution_ids":["https://openalex.org/I76134821"]},{"raw_affiliation_string":"Susanne Greber-Platzer https://orcid.org/0000-0002-3706-8370 Department of Pediatrics and Adolescent Medicine, Division of Pediatric Pulmonology, Allergology and Endocrinology, Medical University of Vienna, Austria (S.G.-P.)","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010266741","display_name":"Shazia Ali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shazia Ali","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","Shazia Ali Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","institution_ids":["https://openalex.org/I186523950"]},{"raw_affiliation_string":"Shazia Ali Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011140765","display_name":"M. Doortje Reijman","orcid":"https://orcid.org/0000-0003-0971-1936","observed_orcids":["https://orcid.org/0000-0003-0971-1936"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I887064364","display_name":"University of Amsterdam","ror":"https://ror.org/04dkp9463","country_code":"NL","type":"education","lineage":["https://openalex.org/I887064364"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Doortje Reijman","raw_affiliation_strings":["Department of Paediatrics, Amsterdam University Medical Centers, Location University of Amsterdam, The Netherlands (A.W., M.D.R.)","M. Doortje Reijman https://orcid.org/0000-0003-0971-1936 Department of Paediatrics, Amsterdam UMC Location University of Amsterdam, The Netherlands (A.W., M.D.R.)"],"raw_orcid":"https://orcid.org/0000-0003-0971-1936","affiliations":[{"raw_affiliation_string":"Department of Paediatrics, Amsterdam University Medical Centers, Location University of Amsterdam, The Netherlands (A.W., M.D.R.)","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I4210151833","https://openalex.org/I887064364"]},{"raw_affiliation_string":"M. Doortje Reijman https://orcid.org/0000-0003-0971-1936 Department of Paediatrics, Amsterdam UMC Location University of Amsterdam, The Netherlands (A.W., M.D.R.)","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020230532","display_name":"Eliot A. Brinton","orcid":"https://orcid.org/0000-0002-9807-4010","observed_orcids":["https://orcid.org/0000-0002-9807-4010"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eliot A Brinton","raw_affiliation_strings":["Utah Lipid Center, Salt Lake City (E.A.B.)","Eliot A Brinton https://orcid.org/0000-0002-9807-4010 Utah Lipid Center, Salt Lake City (E.A.B.)"],"raw_orcid":"https://orcid.org/0000-0002-9807-4010","affiliations":[{"raw_affiliation_string":"Utah Lipid Center, Salt Lake City (E.A.B.)","institution_ids":[]},{"raw_affiliation_string":"Eliot A Brinton https://orcid.org/0000-0002-9807-4010 Utah Lipid Center, Salt Lake City (E.A.B.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059932106","display_name":"Min\u2010Ji Charng","orcid":"https://orcid.org/0000-0002-0949-9026","observed_orcids":["https://orcid.org/0000-0002-0949-9026"]},"institutions":[{"id":"https://openalex.org/I4210156655","display_name":"Shin Kong WHS Memorial Hospital","ror":"https://ror.org/04x744g62","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I4210156655"]}],"countries":["TW"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Min-Ji Charng","raw_affiliation_strings":["Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan (M.-J.C.)","Min-Ji Charng https://orcid.org/0000-0002-0949-9026 Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan (M.-J.C.)"],"raw_orcid":"https://orcid.org/0000-0002-0949-9026","affiliations":[{"raw_affiliation_string":"Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan (M.-J.C.)","institution_ids":["https://openalex.org/I4210156655"]},{"raw_affiliation_string":"Min-Ji Charng https://orcid.org/0000-0002-0949-9026 Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan (M.-J.C.)","institution_ids":["https://openalex.org/I4210156655"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114196389","display_name":"Shubha Srinivasan","orcid":"https://orcid.org/0000-0003-0417-4502","observed_orcids":["https://orcid.org/0000-0003-0417-4502"]},"institutions":[{"id":"https://openalex.org/I129604602","display_name":"The University of Sydney","ror":"https://ror.org/0384j8v12","country_code":"AU","type":"education","lineage":["https://openalex.org/I129604602"]},{"id":"https://openalex.org/I2802384191","display_name":"Children's Hospital at Westmead","ror":"https://ror.org/05k0s5494","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2802384191"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Shubha Srinivasan","raw_affiliation_strings":["Institute of Endocrinology and Diabetes, Children\u2019s Hospital at Westmead, Sydney, Australia (S.S.)","Shubha Srinivasan Institute of Endocrinology and Diabetes, Children's Hospital at Westmead, Sydney, Australia (S.S.). University of Sydney, Australia (S.S.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Endocrinology and Diabetes, Children\u2019s Hospital at Westmead, Sydney, Australia (S.S.)","institution_ids":["https://openalex.org/I2802384191"]},{"raw_affiliation_string":"Shubha Srinivasan Institute of Endocrinology and Diabetes, Children's Hospital at Westmead, Sydney, Australia (S.S.). University of Sydney, Australia (S.S.)","institution_ids":["https://openalex.org/I129604602","https://openalex.org/I2802384191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064919998","display_name":"Carissa Marrie Baker-Smith","orcid":"https://orcid.org/0000-0002-7528-1586","observed_orcids":["https://orcid.org/0000-0002-7528-1586"]},"institutions":[{"id":"https://openalex.org/I4210108049","display_name":"Nemours Children's Health System","ror":"https://ror.org/01mzw6m29","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210108049"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carissa Baker-Smith","raw_affiliation_strings":["Pediatric Preventive Cardiology Program, Nemours Cardiac Center, Nemours Children\u2019s Hospital, Wilmington, DE (C.B.-S.)","Carissa Baker-Smith https://orcid.org/0000-0002-7528-1586 Pediatric Preventive Cardiology Program, Nemours Cardiac Center, Nemours Children's Hospital, Wilmington, DE (C.B.-S.)"],"raw_orcid":"https://orcid.org/0000-0002-7528-1586","affiliations":[{"raw_affiliation_string":"Pediatric Preventive Cardiology Program, Nemours Cardiac Center, Nemours Children\u2019s Hospital, Wilmington, DE (C.B.-S.)","institution_ids":["https://openalex.org/I4210108049"]},{"raw_affiliation_string":"Carissa Baker-Smith https://orcid.org/0000-0002-7528-1586 Pediatric Preventive Cardiology Program, Nemours Cardiac Center, Nemours Children's Hospital, Wilmington, DE (C.B.-S.)","institution_ids":["https://openalex.org/I4210108049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081040737","display_name":"Seth J. Baum","orcid":"https://orcid.org/0000-0003-1202-8126","observed_orcids":["https://orcid.org/0000-0003-1202-8126"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Seth Baum","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)"],"raw_orcid":"https://orcid.org/0000-0003-1202-8126","affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113875434","display_name":"Julie A. Brothers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Julie A. Brothers","raw_affiliation_strings":["Division of Cardiology, Children\u2019s Hospital of Philadelphia, PA (J.A.B.)","Julie A. Brothers Division of Cardiology, Children's Hospital of Philadelphia, PA (J.A.B.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiology, Children\u2019s Hospital of Philadelphia, PA (J.A.B.)","institution_ids":["https://openalex.org/I1335321130"]},{"raw_affiliation_string":"Julie A. Brothers Division of Cardiology, Children's Hospital of Philadelphia, PA (J.A.B.)","institution_ids":["https://openalex.org/I1335321130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054474899","display_name":"Jacob C. Hartz","orcid":"https://orcid.org/0000-0002-6342-4236","observed_orcids":["https://orcid.org/0000-0002-6342-4236"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jacob Hartz","raw_affiliation_strings":["Department of Cardiology, Boston Children\u2019s Hospital, MA (J.H.)","Jacob Hartz Department of Cardiology, Boston Children's Hospital, MA (J.H.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, Boston Children\u2019s Hospital, MA (J.H.)","institution_ids":["https://openalex.org/I1288882113"]},{"raw_affiliation_string":"Jacob Hartz Department of Cardiology, Boston Children's Hospital, MA (J.H.)","institution_ids":["https://openalex.org/I1288882113"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002852988","display_name":"Patrick M. Moriarty","orcid":"https://orcid.org/0000-0001-5548-4493","observed_orcids":["https://orcid.org/0000-0001-5548-4493"]},"institutions":[{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patrick M. Moriarty","raw_affiliation_strings":["Department of Medicine, University of Kansas Medical Center, Kansas City (P.M.M.)","Patrick M. Moriarty https://orcid.org/0000-0001-5548-4493 University of Kansas Medical Center, Kansas City (P.M.M.)"],"raw_orcid":"https://orcid.org/0000-0001-5548-4493","affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Kansas Medical Center, Kansas City (P.M.M.)","institution_ids":["https://openalex.org/I4210128618"]},{"raw_affiliation_string":"Patrick M. Moriarty https://orcid.org/0000-0001-5548-4493 University of Kansas Medical Center, Kansas City (P.M.M.)","institution_ids":["https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091180238","display_name":"Jeanne Mendell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jeanne Mendell","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","Jeanne Mendell Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","institution_ids":["https://openalex.org/I186523950"]},{"raw_affiliation_string":"Jeanne Mendell Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027823647","display_name":"S\u00e9bastien Bihorel","orcid":"https://orcid.org/0000-0002-2326-3335","observed_orcids":["https://orcid.org/0000-0002-2326-3335"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S\u00e9bastien Bihorel","raw_affiliation_strings":["Flourish Research, Boca Raton, FL (S.B.)"],"raw_orcid":"https://orcid.org/0000-0002-2326-3335","affiliations":[{"raw_affiliation_string":"Flourish Research, Boca Raton, FL (S.B.)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077276053","display_name":"Poulabi Banerjee","orcid":"https://orcid.org/0000-0001-5304-9543","observed_orcids":["https://orcid.org/0000-0001-5304-9543"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Poulabi Banerjee","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","Poulabi Banerjee https://orcid.org/0000-0001-5304-9543 Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)"],"raw_orcid":"https://orcid.org/0000-0001-5304-9543","affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","institution_ids":["https://openalex.org/I186523950"]},{"raw_affiliation_string":"Poulabi Banerjee https://orcid.org/0000-0001-5304-9543 Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Richard T. George","orcid":"https://orcid.org/0000-0003-4817-0378","observed_orcids":["https://orcid.org/0000-0003-4817-0378"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard T. George","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","Richard T. George https://orcid.org/0000-0003-4817-0378 Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)"],"raw_orcid":"https://orcid.org/0000-0003-4817-0378","affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","institution_ids":["https://openalex.org/I186523950"]},{"raw_affiliation_string":"Richard T. George https://orcid.org/0000-0003-4817-0378 Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072950568","display_name":"Boaz Hirshberg","orcid":"https://orcid.org/0000-0003-2829-3602","observed_orcids":["https://orcid.org/0000-0003-2829-3602"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Boaz Hirshberg","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","Boaz Hirshberg Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","institution_ids":["https://openalex.org/I186523950"]},{"raw_affiliation_string":"Boaz Hirshberg Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","institution_ids":["https://openalex.org/I186523950"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042842097","display_name":"Robert C. Pordy","orcid":"https://orcid.org/0000-0002-8001-6795","observed_orcids":["https://orcid.org/0000-0002-8001-6795"]},"institutions":[{"id":"https://openalex.org/I186523950","display_name":"Regeneron (United States)","ror":"https://ror.org/02f51rf24","country_code":"US","type":"company","lineage":["https://openalex.org/I186523950"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert Pordy","raw_affiliation_strings":["Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","Robert Pordy https://orcid.org/0000-0002-8001-6795 Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)"],"raw_orcid":"https://orcid.org/0000-0002-8001-6795","affiliations":[{"raw_affiliation_string":"Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","institution_ids":["https://openalex.org/I186523950"]},{"raw_affiliation_string":"Robert Pordy https://orcid.org/0000-0002-8001-6795 Regeneron Pharmaceuticals, Inc, Tarrytown, NY (S.A., J.M., S.B., P.B., R.T.G., B.H., R.P.)","institution_ids":["https://openalex.org/I186523950"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5020436935"],"corresponding_institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I4210151833","https://openalex.org/I887064364"],"apc_list":null,"apc_paid":null,"fwci":17.5617,"has_fulltext":true,"cited_by_count":110,"citation_normalized_percentile":{"value":0.99573824,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":100},"biblio":{"volume":"149","issue":"5","first_page":"343","last_page":"353"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/evinacumab","display_name":"evinacumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/homozygous-familial-hypercholesterolemia","display_name":"homozygous familial hypercholesterolemia","score":0.984000027179718},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.9649999737739563},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.8550000190734863},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.9259999990463257},{"id":"https://openalex.org/keywords/non-hdl-cholesterol","display_name":"non-HDL cholesterol","score":0.8059999942779541},{"id":"https://openalex.org/keywords/apheresis","display_name":"apheresis","score":0.6010000109672546},{"id":"https://openalex.org/keywords/lomitapide","display_name":"lomitapide","score":0.9769999980926514},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.625},{"id":"https://openalex.org/keywords/atherosclerosis-prevention","display_name":"atherosclerosis prevention","score":0.5830000042915344}],"concepts":[{"id":"https://openalex.org/C2779120738","wikidata":"https://www.wikidata.org/wiki/Q2711291","display_name":"Familial hypercholesterolemia","level":3,"score":0.9288753271102905},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8929098844528198},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6144712567329407},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.558336615562439},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.5426296591758728},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5327131152153015},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.49817490577697754},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.4571426510810852},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4559711515903473},{"id":"https://openalex.org/C2780955771","wikidata":"https://www.wikidata.org/wiki/Q183425","display_name":"Abdominal pain","level":2,"score":0.41566768288612366},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.38110777735710144},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3493150770664215},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.33456799387931824}],"mesh":[{"descriptor_ui":"D000090542","descriptor_name":"Homozygous Familial Hypercholesterolemia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006720","descriptor_name":"Homozygote","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006938","descriptor_name":"Hyperlipoproteinemia Type II","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1161/circulationaha.123.065529","doi":"https://doi.org/10.1161/circulationaha.123.065529","is_oa":true,"landing_page_url":"https://doi.org/10.1161/circulationaha.123.065529","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.123.065529","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10814999","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10814999","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10814999/pdf/cir-149-343.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Text"},{"id":"pmid:37860863","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37860863","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire/6da4359e-cae2-4efe-8664-1c342f99ee67","doi":null,"is_oa":true,"landing_page_url":"https://pure.amsterdamumc.nl/files/150710379/Evinacumab-for-pediatric-patients-with-homozygous-familial-hypercholesterolemia.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Wiegman, A, Greber-Platzer, S, Ali, S, Reijman, M D, Brinton, E A, Charng, M-J, Srinivasan, S, Baker-Smith, C, Baum, S, Brothers, J A, Hartz, J, Moriarty, P M, Mendell, J, Bihorel, S B, Banerjee, P, George, R T, Hirshberg, B & Pordy, R 2024, 'Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia', Circulation, vol. 149, no. 5, pp. 343-353. https://doi.org/10.1161/CIRCULATIONAHA.123.065529","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1161/circulationaha.123.065529","doi":"https://doi.org/10.1161/circulationaha.123.065529","is_oa":true,"landing_page_url":"https://doi.org/10.1161/circulationaha.123.065529","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.123.065529","source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320311600","display_name":"Regeneron Pharmaceuticals","ror":"https://ror.org/02f51rf24"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4387798656.pdf","grobid_xml":"https://content.openalex.org/works/W4387798656.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W1511397928","https://openalex.org/W1944135887","https://openalex.org/W1993194335","https://openalex.org/W2009257021","https://openalex.org/W2011279900","https://openalex.org/W2017602185","https://openalex.org/W2023735564","https://openalex.org/W2026205222","https://openalex.org/W2051614350","https://openalex.org/W2057394745","https://openalex.org/W2104299102","https://openalex.org/W2116015900","https://openalex.org/W2116404316","https://openalex.org/W2142627469","https://openalex.org/W2165624352","https://openalex.org/W2262354148","https://openalex.org/W2302032525","https://openalex.org/W2588614813","https://openalex.org/W2623127111","https://openalex.org/W2745653865","https://openalex.org/W2778912952","https://openalex.org/W2788460204","https://openalex.org/W2792934527","https://openalex.org/W2894417323","https://openalex.org/W2904411616","https://openalex.org/W2914063169","https://openalex.org/W2945658222","https://openalex.org/W2977398427","https://openalex.org/W2980876689","https://openalex.org/W3000314523","https://openalex.org/W3039823791","https://openalex.org/W3061843793","https://openalex.org/W3072652402","https://openalex.org/W3092331570","https://openalex.org/W3137520281","https://openalex.org/W3158803074","https://openalex.org/W3199223781","https://openalex.org/W3204786617","https://openalex.org/W3217115154","https://openalex.org/W4210272691","https://openalex.org/W4224442673","https://openalex.org/W4367369519","https://openalex.org/W4367668438"],"related_works":["https://openalex.org/W4386143895","https://openalex.org/W4386968745","https://openalex.org/W4400936039","https://openalex.org/W4410351175","https://openalex.org/W7116656716","https://openalex.org/W4389952914","https://openalex.org/W7166819411","https://openalex.org/W4380053056","https://openalex.org/W3217115154","https://openalex.org/W4225896772"],"abstract_inverted_index":{"BACKGROUND:":[0],"Homozygous":[1],"familial":[2],"hypercholesterolemia":[3],"(HoFH)":[4],"is":[5],"a":[6,43,70,86,155,229],"rare":[7],"genetic":[8],"disorder":[9],"characterized":[10],"by":[11,248],"severely":[12,29],"elevated":[13,30],"low-density":[14],"lipoprotein":[15,174],"cholesterol":[16,175,180],"(LDL-C)":[17],"levels":[18,247],"due":[19],"to":[20,101,165,204],"profoundly":[21],"defective":[22],"LDL":[23],"receptor":[24],"(LDLR)":[25],"function.":[26],"Given":[27],"that":[28,201],"LDL-C":[31,116,146,158,240,246],"starts":[32],"in":[33,52,75,150,191,251],"utero,":[34],"atherosclerosis":[35],"often":[36],"presents":[37],"during":[38],"childhood":[39],"or":[40],"adolescence,":[41],"creating":[42],"largely":[44],"unmet":[45],"need":[46],"for":[47,232],"aggressive":[48],"LDLR-independent":[49,72,124],"lipid-lowering":[50,73,121,243],"therapies":[51],"young":[53],"patients":[54,77,99,234],"with":[55,78,106,115,128,147,154,235],"HoFH.":[56],"Here":[57],"we":[58],"present":[59],"the":[60,64,151],"first":[61,152],"evaluation":[62],"of":[63,68,85,104,160,216],"efficacy":[65],"and":[66,83,112,126,140,178,208,237,255],"safety":[67],"evinacumab,":[69],"novel":[71],"therapy,":[74,244],"pediatric":[76,233],"HoFH":[79,109,236],"from":[80,163],"parts":[81],"A":[82],"B":[84],"3-part":[87],"study.":[88],"METHODS:":[89],"The":[90],"phase":[91],"3,":[92],"part":[93],"B,":[94],"open-label":[95],"study":[96],"treated":[97],"14":[98],"5":[100],"11":[102],"years":[103],"age":[105],"genetically":[107],"proven":[108],"(true":[110],"homozygotes":[111],"compound":[113],"heterozygotes)":[114],">130":[117],"mg/dL,":[118],"despite":[119,241],"optimized":[120,242],"therapy":[122],"(including":[123],"apheresis":[125],"lomitapide),":[127],"intravenous":[129],"evinacumab":[130],"15":[131],"mg/kg":[132],"every":[133],"4":[134],"weeks.":[135],"RESULTS:":[136],"Evinacumab":[137,227],"treatment":[138,231],"rapidly":[139],"durably":[141],"(through":[142],"week":[143,166],"24)":[144],"decreased":[145],"profound":[148],"reduction":[149,159],"week,":[153],"mean":[156],"(SE)":[157],"-48.3%":[161],"(10.4%)":[162],"baseline":[164],"24.":[167],"ApoB":[168],"(mean":[169],"[SE],":[170],"-41.3%":[171],"[9.0%]),":[172],"non-high-density":[173],"(-48.9%":[176],"[9.8%]),":[177],"total":[179],"(-49.1%":[181],"[8.1%])":[182],"were":[183,189,202],"similarly":[184],"decreased.":[185],"Treatment-emergent":[186],"adverse":[187,214],"events":[188,200],"reported":[190,199],"10":[192],"(71.4%)":[193],"patients;":[194],"however,":[195],"only":[196],"2":[197],"(14.3%)":[198],"considered":[203,224],"be":[205],"treatment-related":[206],"(nausea":[207],"abdominal":[209],"pain).":[210],"One":[211],"serious":[212],"treatment-emergent":[213],"event":[215],"tonsillitis":[217],"occurred":[218],"(n=1),":[219],"but":[220],"this":[221],"was":[222],"not":[223],"treatment-related.":[225],"CONCLUSIONS:":[226],"constitutes":[228],"new":[230],"inadequately":[238],"controlled":[239],"lowering":[245],"nearly":[249],"half":[250],"these":[252],"extremely":[253],"high-risk":[254],"difficult-to-treat":[256],"individuals.":[257],"REGISTRATION:":[258],"URL:":[259],"https://www.clinicaltrials.gov;":[260],"Unique":[261],"identifier:":[262],"NCT04233918.":[263]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4387798656","counts_by_year":[{"year":2026,"cited_by_count":41},{"year":2025,"cited_by_count":43},{"year":2024,"cited_by_count":24},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2023-10-21T00:00:00"}
